PCT-assisted antibiotic therapy

Size: px
Start display at page:

Download "PCT-assisted antibiotic therapy"

Transcription

1 PCT-assisted antibiotic therapy Prof. Zsolt Molnár Department of Anaesthesia and Intensive Care University of Szeged Hungary

2 Problems with the definition of sepsis

3 Definitive diagnoses with definitive treatment

4 Sepsis is not a definitive diagnosis Sepsis-syndrome and Las Vegas : Fever or hypothermia (> 38.3 o C or < 35.0 o C) Tachycardia (>90/min) Leukocytosis or leukopenia (> cells/mm 3, < 4000cells/mm 3, or > 10% immature forms) Hypotension (<90mmHg)

5 Sepsis is not a definitive diagnosis Sepsis-syndrome and Las Vegas : Fever or hypothermia (> 38.3 o C or < 35.0 o C) Tachycardia (>90/min) Leukocytosis or leukopenia (> cells/mm 3, < 4000cells/mm 3, or > 10% immature forms) Hypotension (<90mmHg)

6 Sepsis is not a definitive diagnosis Consensus conference ACCP/SCCM: Infection Bacteraemia Systemic inflammatory response syndrome (SIRS) Sepsis = SIRS + Infection Severe sepsis (Sepsis + one organ dysfunction) Septic shock (hypoperfusion despite adequate fluid load) Multiple System Organ Failure (MSOF) ACCP/SCCM. Crit Care Med 1992; 20: 864

7 Sepsis definition SSC 2012 Sepsis is not a disease but a consensus

8 Pathomechanism I n s u l t Endotoxin, Trauma, Sterile inflammation, Operation, etc. Humoral activity Interferon, Complement Sepsis M a and c r o p Love h a g e s TNF; IL-1,6,10; PAF Fisiol. reactions Fever, Metabolic changes E n d o t h e l P M N FR, PAF, Chemotaxis It isn t the insult, but host response what determines NO, severity E-selectin, NFkB and outcome Sepsis, SIRS MSOF Molnár and Shearer Br J Int Care Med 1998; 8: 12

9 DAMP = Damage Assosiated Molecular Pattern PAMP = Pathogen Associated Molecular Pattern DAMP SIRS versus PAMP SIRS G+ Surgery, Trauma, Pancreatitis Isch-reperf. G- F (Courtesy of Janos Fazakas)

10 PCT kinetics after esophagectomy 15 S = 130 NS = 23 *p<0.05 * 2-5 ng/ml Procalcitonin (ng ml-1) 10 5 t 0 t 24 t 48 0 Survivors Non-survivors t 72 Data are presented as minimum, maximum, 25-75% percentile and median. For statistical analysis Mann-Whitney U test was used. Szakmány T, Molnár Z. Can J Anaesth 2003; 50:

11 The expected course of PCT concentrations in a surgical patient without serious bacterial infection Lindberg et al., Scand J Clin Lab Invest 2002; 62:

12 Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock Clec h et al. Crit Care Med 2006; 34: Medical patients: SIRS: PCT = 0.3 ( ) ng/ml Septic shock: PCT = 8.4 ( ) ng/ml PAMP Surgical patients: SIRS: PCT = 5.7 ( ) ng/ml Septic shock: PCT = 34 (7-76) ng/ml DAMP+PAMP Sepsis homogenious group of patients ie One size does not fit all 1 ng/ml, sens: 80% - spec: 94% 9.7 ng/ml, sens: 91% - spec: 74%

13 Nature Reviews Immunology Volume 13 December Proinlflammation Antiinlflammation

14 Nature Reviews Immunology Volume 13 December Overwhelming inflammation vs. prolonged immunosupression: Both can be deadly! Proinlflammation Antiinlflammation

15 Immunosupression over time less PCT response Priority of PCT kinetics over absolute values?

16

17 Is this patient septic or not?

18 I have never treated SEPSIS in my life! But

19 Does the patient have infection or not? Infection = ABs No infection = No ABs

20 Signs of infection Clinical signs: Most important Not good enough Fever (>38 o C), WBC (>12 000): Low sensitivity (~50%) Poooor! Galicier L and Richet H. Infect Control Hosp Epidemol 1985; 6: 487 Microbiology: Results: 24 hours or more Very late!

21 We need biomarkers! At least 173 of them!! My favourite is: procalcitonin (PCT)

22 The 3 fundamental questions to answer 1. Is there infection should I start empirical ABs? 2. Is it effective? 3. When should I stop?

23 Is there infection?

24 Christ-Crain M, et al. Lancet 2004; 363: Relative reduction in AB exposure : 50% No difference in outcome Proven infection: 21%

25 Layios N, et al. Crit Care Med 2012; 39: Limitations: 40% surgical patients (0.25, 0.5, 1.0 ng/ml cut off too low) In the whole sample ~90% of patients with PCT>1ng/ml received ABs

26 The EProK-study Trásy D et al.,(in review)

27 Increasing procalcitonin may be a good indicator of starting empirical antibiotic treatment in critically ill patients Patients with suspected infection = 209 PCT available at T -1 = 114 Infection = 85 No-infection = 29

28 Predicting infection (T -1 T 0 ) Trásy D et al.,(manuscript under submission) 77 % 85 % Kinetics over absolute values! Forget about CRP, WBC and T!

29 Tsangaris at al.: BMC Infectious Disease 2009;9: Infection Increasing PCT/24 h: May be a good indicator of infection The PCT value on the day of fever onset must be compared with previous day PCT values (chronic critically ill patient) No change in PCT/24 h: May be a good indicator of no infection Day before fever No infection

30 How does it work in clinical practice? Medical patients: SIRS: PCT = 0.3 ( ) ng/ml Septic shock: PCT = 8.4 ( ) ng/ml Clec h et al. Crit Care Med 2006; 34: Surgical patients: You admitted 2 hemodynamically stable critically ill patients from the ward SIRS: PCT = 5.7 ( ) ng/ml Septic shock: PCT = 34 (7-76) ng/ml AB yes? AB yes AB no 1 ng/ml, sens: 80% - spec: 94% 3 ng/ml 1-3 ng/ml 5-3 ng/ml AB no? AB yes AB no 9.7 ng/ml, sens: 91% - spec: 74%

31 Is the AB effective?

32 International guidelines

33 local protocols

34 BMC Infectious Diseases 2007, 7:21 28%

35 The EProK-study Trásy D et al.,(under review)

36 The EProK-study Patients with suspected infection= 209 Proven infection = 169 Effective AB = 127 (77%) Ineffective AB = 38 (23%) No infection = 44 Kinetics of PCT during T 0 -T 16 -T 24 : vs. Trásy D et al.,(under review) May indicate effective/ineffective AB treatment

37 PCT-kinetics to predict AB-effectiveness Trásy D et al.,(under review) PCT t 0 - t 16 PCT t 0 - t 24 55% 71% ( ) 75% ( ) 46% ( ) 89% ( ) < % 73% ( ) 82% ( ) 56% ( ) 91% ( ) <0.001 ICU mortality: Effective: 35%, Ineffective: 62%, p<0.001

38 Surgical and medical patients

39 The EProK-study Trásy D et al.,(under review) Medical: ~ 5ng/ml Surgical: ~20 ng/ml Absolute values are different, but kinetics are similar

40 Stopping AB-therapy

41 Lancet 2010; 375:

42 Mean difference without ABs: 2.7 days Relative reduction in AB exposure: 23% Lancet 2010; 375:

43 Inexperienced units Low (and fixed!) cut off values (<0.1 ng/ml or >90% decrease) Powered for 25% (3.75 day) reduction underpowered to show a significant 2 day reduction

44 Surviving Sepsis Guideline Dellinger RP et al Crit Care Med 2013; 41:

45 The 3 main answers with PCT 1. Is there infection? 2. Is the AB effective? 3. When to stop? Brave to withhold ABs Helps decision within h You may reduce AB exposure

46 Final thoughts

47 The most important lesson Auguste Rodin: The Thinker (1880)

48 Motto It doesn t matter whether you ve done the right thing, but whether you ve done everything to do the right thing (Rephrased by ZM from Bhagavad Gita)

49 Free for junior doctors (<29)!

PCT-assisted antibiotic therapy

PCT-assisted antibiotic therapy PCT-assisted antibiotic therapy Prof. Zsolt Molnár zsoltmolna@gmail.com Department of Anaesthesia and Intensive Care University of Szeged Hungary Problems with the definition of sepsis Sepsis is not a

More information

Procalcitonin kinetics guided antibiotic management of the critically ill patient

Procalcitonin kinetics guided antibiotic management of the critically ill patient Procalcitonin kinetics guided antibiotic management of the critically ill patient András LOVAS MD, PhD, EDIC, EDAIC University of Szeged, Hungary Department of Anaesthesiology and Intensive Therapy 19/11/2016,

More information

Adsorbtion of Cytokines Early in Septic Shock: the ACESS trial

Adsorbtion of Cytokines Early in Septic Shock: the ACESS trial Adsorbtion of Cytokines Early in Septic Shock: the ACESS trial Prof. Zsolt Molnár zsoltmolna@gmail.com Department of Anaesthesia and Intensive Care University of Szeged Hungary Pathophysiology Local insult

More information

Importance of kinetics of procalcitonin in septic patients. János Fazakas MD, PhD Semmelweis University, Department of Transplantation and Surgery

Importance of kinetics of procalcitonin in septic patients. János Fazakas MD, PhD Semmelweis University, Department of Transplantation and Surgery Importance of kinetics of procalcitonin in septic patients János Fazakas MD, PhD Semmelweis University, Department of Transplantation and Surgery Host pathogen interactions the innate and the adaptive

More information

Fluorescence immunoassay Point of care test Wide range PCT. whole blood. plasma. serum

Fluorescence immunoassay Point of care test Wide range PCT. whole blood. plasma. serum Fluorescence immunoassay Point of care test Wide range PCT whole blood serum plasma ichroma PCT Description ichroma PCT along with ichroma Reader is a fluorescence immunoassay for quantitative determination

More information

The Usefulness of Sepsis Biomarkers. Dr Vineya Rai Department of Anesthesiology University of Malaya

The Usefulness of Sepsis Biomarkers. Dr Vineya Rai Department of Anesthesiology University of Malaya The Usefulness of Sepsis Biomarkers Dr Vineya Rai Department of Anesthesiology University of Malaya 1 What is Sepsis? Whole Body Inflammatory State + Infection 2 Incidence and Burden of Sepsis in US In

More information

Disclosures. Objectives. Procalcitonin: Pearls and Pitfalls in Daily Practice

Disclosures. Objectives. Procalcitonin: Pearls and Pitfalls in Daily Practice Procalcitonin: Pearls and Pitfalls in Daily Practice Sarah K Harrison, PharmD, BCCCP Clinical Pearl Disclosures The author of this presentation has no disclosures concerning possible financial or personal

More information

ADVANCES IN BIOMARKER TESTING FOR SEPSIS AND BACTERIAL INFECTIONS

ADVANCES IN BIOMARKER TESTING FOR SEPSIS AND BACTERIAL INFECTIONS ADVANCES IN BIOMARKER TESTING FOR SEPSIS AND BACTERIAL INFECTIONS ERIC H GLUCK MD JD FCCP FCCM DIRECTOR OF CRITICAL SERVICES SWEDISH COVENANT HOSPTIAL DISCLOSURES: Speaking engagements and consulting:

More information

Use of surrogate inflammatory markers in the diagnosis & monitoring of patients with severe sepsis

Use of surrogate inflammatory markers in the diagnosis & monitoring of patients with severe sepsis Thursday 11 th June 2015 Use of surrogate inflammatory markers in the diagnosis & monitoring of patients with severe sepsis Dr Duncan Wyncoll Guy s & St Thomas NHS Trust, London Conflicts of Interest In

More information

Biomarkers for streamlining of Antibiotics in patients with severe infection.

Biomarkers for streamlining of Antibiotics in patients with severe infection. Biomarkers for streamlining of Antibiotics in patients with severe infection. Philipp Schuetz, MD Feb, 2013 Email: Schuetzph@gmail.com You see this patient in your ICU -3d: Cough, Dyspnoe, Sputum T: 38.8

More information

SHOULD THERAPEUTIC AGENTS FOR SEPSIS TARGET THE GLYCOCALYX?

SHOULD THERAPEUTIC AGENTS FOR SEPSIS TARGET THE GLYCOCALYX? SHOULD THERAPEUTIC AGENTS FOR SEPSIS TARGET THE GLYCOCALYX? Sir Ganga Ram Hospital New Delhi, India Dr. Seema Bhargava Senior Consultant & Chairperson Department of Biochemistry & Professor, GRIPMER Sir

More information

BIOMARKERS IN SEPSIS

BIOMARKERS IN SEPSIS BIOMARKERS IN SEPSIS Dr. Syed Ghulam Mogni Mowla Assistant Professor, Medicine, DMC BSMCON 17 WHY WE NEED TO KNOW Sepsis and its complications are a common cause of infectious disease illness and mortality

More information

Research Article In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between Sepsis and SIRS than CRP, Il-6, or LBP

Research Article In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between Sepsis and SIRS than CRP, Il-6, or LBP Critical Care Research and Practice Volume 2011, Article ID 594645, 6 pages doi:10.1155/2011/594645 Research Article In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between

More information

Usefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège

Usefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège Usefulness of Procalcitonin in the management of Infections in ICU P Damas CHU Sart Tilman Liège Procalcitonin Peptide 116 AA Produced by parenchymal cells during «sepsis»: IL1, TNF, IL6 : stimulators

More information

Norepinephrine in septic shock

Norepinephrine in septic shock Norepinephrine in septic shock Prof. Zsolt Molnár zsoltmolna@gmail.com Department of Anaesthesia and Intensive Therapy University of Szeged, Hungary A few months ago should we give it earlier? (Courtesy

More information

Using procalcitonin (PCT) to improve the odds in sepsis management

Using procalcitonin (PCT) to improve the odds in sepsis management Using procalcitonin (PCT) to improve the odds in sepsis management Disclaimer This guide provides information for healthcare professionals on the optimal use of procalcitonin (PCT) testing and the subsequent

More information

L utilizzo della Procalcitonina in Medicina d Urgenza

L utilizzo della Procalcitonina in Medicina d Urgenza L utilizzo della Procalcitonina in Medicina d Urgenza Stefania Battista Dirigente Medico S.C. Medicina d Urgenza Azienda Ospedaliero-Universitaria San Giovanni Battista di Torino Savona, 15 ottobre 2009

More information

Use of procalcitonin assay to streamline antibiotic usage. Dr Kristine Luk

Use of procalcitonin assay to streamline antibiotic usage. Dr Kristine Luk Use of procalcitonin assay to streamline antibiotic usage Dr Kristine Luk Outline Procalcitonin physiology & kinetics Limitations Different settings - primary care & AED - critically ill patients - neutropenic

More information

5/1/2015 SEPSIS SURVIVING SEPSIS CAMPAIGN HOW TO APPROACH THE POSSIBLE SEPTIC CHILD 2015 INFECTION CAN BE CONFIRMED BY:

5/1/2015 SEPSIS SURVIVING SEPSIS CAMPAIGN HOW TO APPROACH THE POSSIBLE SEPTIC CHILD 2015 INFECTION CAN BE CONFIRMED BY: SURVIVING SEPSIS CAMPAIGN HOW TO APPROACH THE POSSIBLE SEPTIC CHILD 2015 Omer Nasiroglu MD Baptist Children s Hospital Pediatric Emergency Department SEPSIS IS A SYSTEMIC INFLAMMATORY RESPONSE SYNDROME

More information

DIAGNOSIS AND INVESTIGATIONS FOR SEPSIS. B. Mrara

DIAGNOSIS AND INVESTIGATIONS FOR SEPSIS. B. Mrara DIAGNOSIS AND INVESTIGATIONS FOR SEPSIS B. Mrara CH C.H. Baragwanath ICU OUTLINE Introduction Diagnostic issues in sepsis Diagnosis and investigations for sepsis: clinical and laboratory lb investigations

More information

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID Septic Shock Rontgene M. Solante, MD, FPCP,FPSMID Learning Objectives Identify situations wherein high or low BP are hemodynamically significant Recognize complications arising from BP emergencies Manage

More information

Sepsis the clinical syndrome

Sepsis the clinical syndrome Sepsis the clinical syndrome João Gonçalves Pereira ICU director Vila Franca Xira Hospital Systemic Inflamatory Response 2 Temperature 38ºC or 36ºC bacteraemia other trauma HR 90/min INFECTION RR 20/min

More information

Biomarkers in sepsis: Utility in critical care

Biomarkers in sepsis: Utility in critical care Biomarkers in sepsis: Utility in critical care Fathima Paruk, PhD Charlotte Maxeke Johannesburg Academic Hospital and University of Witwatersrand Kumar A et al, Chest 2009; 136:1237-48. von Gunten et al

More information

Biomarcadores. orientação terapêutica

Biomarcadores. orientação terapêutica Biomarcadores estratificação do risco e orientação terapêutica Pedro Póvoa Faculdade de Ciências Médicas Universidade Nova de Lisboa Unidade de Cuidados Intensivos Médicos Hospital de São Francisco Xavier

More information

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012 Clinicians decision-making capability Guideline recommendations Sepsis is an important issue 8.7%

More information

BIOMARKERS IN SEPSIS: DO THEY REALLY GUIDE US? Asist. Prof. M.D. Mehmet Akif KARAMERCAN Gazi University School of Medicine Depertment of Emergency

BIOMARKERS IN SEPSIS: DO THEY REALLY GUIDE US? Asist. Prof. M.D. Mehmet Akif KARAMERCAN Gazi University School of Medicine Depertment of Emergency BIOMARKERS IN SEPSIS: DO THEY REALLY GUIDE US? Asist. Prof. M.D. Mehmet Akif KARAMERCAN Gazi University School of Medicine Depertment of Emergency Medicine 1 NO CONFLICT OF INTEREST 2 We do not fully understand

More information

Clinical Guide to Use of PROCALCITONIN. for Diagnosis and PCT-Guided Antibiotic Therapy

Clinical Guide to Use of PROCALCITONIN. for Diagnosis and PCT-Guided Antibiotic Therapy Clinical Guide to Use of PROCALCITONIN for Diagnosis and PCT-Guided Antibiotic Therapy The content of this booklet was kindly written by: Philipp Schuetz, MD, MPH Privat Dozent for Endocrinology and Internal

More information

Procalcitonin YUKON KUSKOKWIM HEALTH CORPORATION PRESENTED BY: CURT BUCHHOLZ, MD AUGUST 2017

Procalcitonin YUKON KUSKOKWIM HEALTH CORPORATION PRESENTED BY: CURT BUCHHOLZ, MD AUGUST 2017 Procalcitonin YUKON KUSKOKWIM HEALTH CORPORATION PRESENTED BY: CURT BUCHHOLZ, MD AUGUST 2017 Procalcitonin (PCT) PCT isbeing studied as a biomarker for infection PCT consists of 116 amino

More information

Prognostic role of adrenomedullin in sepsis

Prognostic role of adrenomedullin in sepsis Int. J. Adv. Res. Biol. Sci. (2016). 3(5): 136-141 International Journal of Advanced Research in Biological Sciences ISSN: 2348-8069 www.ijarbs.com Volume 3, Issue 5-2016 Research Article Prognostic role

More information

SEPSIS AND SEPTICEMIA St. Charles Bend / Dec. 18, 2015

SEPSIS AND SEPTICEMIA St. Charles Bend / Dec. 18, 2015 SEPSIS AND SEPTICEMIA St. Charles Bend / Dec. 18, 2015 DEFINITIONS SYSTEMIC INFLAMMATORY RESPONSE SYNDROME SEPSIS SEVERE SEPSIS SEPTIC SHOCK MULTIPLE ORGAN FAILURE BACTEREMIA SEPTICEMIA THOMAS C CESARIO

More information

Early procalcitonin kinetics and adequate empiric antibiotic therapy in critically ill

Early procalcitonin kinetics and adequate empiric antibiotic therapy in critically ill Early procalcitonin kinetics and adequate empiric antibiotic therapy in critically ill PhD Thesis Domonkos Trásy M.D. Department of Anaesthesiology and Intensive Therapy Doctoral School of Multidisciplinary

More information

Research paper 45. Address: Department of Anaesthesiology, University of Erlangen-Nuremburg, Krankenhausstr. 12, D Erlangan, Germany.

Research paper 45. Address: Department of Anaesthesiology, University of Erlangen-Nuremburg, Krankenhausstr. 12, D Erlangan, Germany. Research paper 45 Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS Michael Meisner, Klaus Tschaikowsky,

More information

Key Points. Angus DC: Crit Care Med 29:1303, 2001

Key Points. Angus DC: Crit Care Med 29:1303, 2001 Sepsis Key Points Sepsis is the combination of a known or suspected infection and an accompanying systemic inflammatory response (SIRS) Severe sepsis is sepsis with acute dysfunction of one or more organ

More information

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital R2R: Severe sepsis/septic shock Surat Tongyoo Critical care medicine Siriraj Hospital Diagnostic criteria ACCP/SCCM consensus conference 1991 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

More information

Diagnostic role of soluble triggering receptor expressed on myeloid cell-1 in patients with sepsis

Diagnostic role of soluble triggering receptor expressed on myeloid cell-1 in patients with sepsis 190 Wang et al Original Article Diagnostic role of soluble triggering receptor expressed on myeloid cell-1 in patients with sepsis Hong-xia Wang, Bing Chen Department of Emergency Medicine, Second Hospital

More information

PCT. PCT in Bacterial Infections and Sepsis. Early Diagnosis. Assessment of Severity and Prognosis. Support for Therapeutic Decision Making

PCT. PCT in Bacterial Infections and Sepsis. Early Diagnosis. Assessment of Severity and Prognosis. Support for Therapeutic Decision Making PCT PCT in Bacterial Infections and Sepsis Early Diagnosis Assessment of Severity and Prognosis Support for Therapeutic Decision Making Diagnosis and monitoring of sepsis Clinical need for earlier detection

More information

Sepsis: Mitigating Denials Amid Definition Disparity

Sepsis: Mitigating Denials Amid Definition Disparity Sepsis: Mitigating Denials Amid Definition Disparity White Paper - April 2017 Sepsis Criteria at a Glance The Society of Critical Care Medicine (SCCM) met in 2016 to update the definition of sepsis. During

More information

Sepsis as Seen by the CMO. Randy C. Roth, MD Chief Medical Officer

Sepsis as Seen by the CMO. Randy C. Roth, MD Chief Medical Officer Sepsis as Seen by the CMO Randy C. Roth, MD Chief Medical Officer 1 Challenges of Sepsis Sepsis, like many disease processes, is much more than a clinical challenge. For Hospitalists, we are treating the

More information

Guess or get it right?

Guess or get it right? Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders

More information

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK Alexandria Rydz BACKGROUND- SEPSIS Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated

More information

/////// Procalcitonin. Solutions for Emergency Diagnostics. A Novel Biomarker for Bacterial Infections and Sepsis. VIDAS Emergency Assays

/////// Procalcitonin. Solutions for Emergency Diagnostics. A Novel Biomarker for Bacterial Infections and Sepsis. VIDAS Emergency Assays /////// Solutions for Emergency Diagnostics 2015 BIOMÉRIEUX, INC. BIOMÉRIEUX, THE BLUE LOGO AND VIDAS ARE USED PENDING AND/OR REGISTERED TRADEMARKS BELONGING TO BIOMÉRIEUX SA OR ONE OF ITS SUBSIDIARIES

More information

Current State of Pediatric Sepsis. Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018

Current State of Pediatric Sepsis. Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018 Current State of Pediatric Sepsis Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018 Objectives Review the history of pediatric sepsis Review the current definition of pediatric sepsis Review triage

More information

Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment

Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment What is sepsis? Life-threatening organ dysfunction caused by a dysregulated host response to infection A 1991 consensus

More information

Diagnosis and Management of Sepsis. Disclosures

Diagnosis and Management of Sepsis. Disclosures Diagnosis and Management of Sepsis David Shimabukuro, MDCM Medical Director, 13 ICU Physician Lead, UCSF Sepsis Bundle Compliance and Mortality Reduction I have no disclosures Disclosures 1 The following

More information

Endothelium as a part of septic Multiple Organ Dysfunction Syndrome (MODS)-is endocan an answer?

Endothelium as a part of septic Multiple Organ Dysfunction Syndrome (MODS)-is endocan an answer? Endothelium as a part of septic Multiple Organ Dysfunction Syndrome (MODS)-is endocan an answer? Małgorzata Lipinska-Gediga Department of Anaesthesiology and Intensive Therapy Medical University Wroclaw,

More information

John Park, MD Assistant Professor of Medicine

John Park, MD Assistant Professor of Medicine John Park, MD Assistant Professor of Medicine Faculty photo will be placed here park.john@mayo.edu 2015 MFMER 3543652-1 Sepsis Out with the Old, In with the New Mayo School of Continuous Professional Development

More information

Management of Severe Sepsis:

Management of Severe Sepsis: Management of Severe Sepsis: Update from the Surviving Sepsis Campaign Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University NONE Disclosures Review evidence-based international sepsis

More information

Updates in Sepsis 2017

Updates in Sepsis 2017 Mortality Cases Total U.S. Population/1,000 Updates in 2017 Joshua Solomon, M.D. Associate Professor of Medicine National Jewish Health University of Colorado Denver Background New Definition of New Trials

More information

Sepsis Management: Past, Present, and Future

Sepsis Management: Past, Present, and Future Sepsis Management: Past, Present, and Future Benjamin Ferrell, MD Tennessee ACP Meeting October 28, 2017 Learning Objectives Identify the most updated definition and clinical criteria for sepsis Describe

More information

Spotting and Surviving Sepsis

Spotting and Surviving Sepsis Spotting and Surviving Sepsis Thomas Koshy, Ph.D. Sr. Director, Scientific Affairs Alere September 12, 2013 FOR INTERNAL USE ONLY. NOT FOR PRINT OR DISTRIBUTION 1 Learning Objectives Discuss the scope

More information

Sepsis and Septicemia: Clear up Coding and Documentation Confusion october 2009

Sepsis and Septicemia: Clear up Coding and Documentation Confusion october 2009 Sepsis and Septicemia: Clear Up Coding and Documentation Confusion W h i t e p a p e r Sepsis. Severe sepsis. SIRS. Septicemia. Unfortunately, this isn t a case of tomato, tomahto. Coders and physicians

More information

SURVIVING SEPSIS: Early Management Saves Lives

SURVIVING SEPSIS: Early Management Saves Lives SURVIVING SEPSIS: Early Management Saves Lives Pat Posa RN, BSN, MSA System Performance Improvement Leader St. Joseph Mercy Health System Ann Arbor, MI Patricia.posa@stjoeshealth.org Objectives a. Understand

More information

Detecting and Removing Endotoxin in sepsis

Detecting and Removing Endotoxin in sepsis Toronto 2015 Detecting and Removing Endotoxin in sepsis Claudio Ronco, MD Department of Nephrology Dialysis and Transplantation International Renal Research Institute San Bortolo Hospital Vicenza Italy

More information

HE Model for Sepsis POCT

HE Model for Sepsis POCT HE Model for Sepsis POCT 1. To analyse the impact of a diagnostic test on the treatment of patients with sepsis, using patient data and expert elicitation 2. To build a business case to use POCT in A&E

More information

Initial Resuscitation of Sepsis & Septic Shock

Initial Resuscitation of Sepsis & Septic Shock Initial Resuscitation of Sepsis & Septic Shock Dr. Fatema Ahmed MD (Critical Care Medicine) FCPS (Medicine) Associate professor Dept. of Critical Care Medicine BIRDEM General Hospital Is Sepsis a known

More information

The Sepsis Timebomb. James Wigfull Critical Care and Anaesthesia Sheffield Teaching Hospitals

The Sepsis Timebomb. James Wigfull Critical Care and Anaesthesia Sheffield Teaching Hospitals The Sepsis Timebomb James Wigfull Critical Care and Anaesthesia Sheffield Teaching Hospitals Relationship of SIRS, Sepsis and Infection BACTEREMIA PANCREATITIS INFECTION FUNGEMIA PARASITEMIA VIREMIA SEPSIS

More information

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014 Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014 Presenters Mark Blaney, RN Regional Nurse Educator CHI Franciscan Health Karen Lautermilch Director, Quality & Performance

More information

Biomarkers in sepsis. Dr S Omar University of Witwatersrand CHBAH Bara ICU

Biomarkers in sepsis. Dr S Omar University of Witwatersrand CHBAH Bara ICU Biomarkers in sepsis Dr S Omar University of Witwatersrand CHBAH Bara ICU Procalcitonin PCT biomarker 1993- described as a sepsis associated protein Identical to the precursor protein of calcitonin which

More information

Septic shock in children. Is it different than adults? Peter Kanizsai, MD, PhD associate professor in emergency medicine

Septic shock in children. Is it different than adults? Peter Kanizsai, MD, PhD associate professor in emergency medicine Septic shock in children. Is it different than adults? Peter Kanizsai, MD, PhD associate professor in emergency medicine http://www.ipaustralia.com.au/applicant/clinical-excellence-commission/trademarks/1473265/

More information

The Use of Procalcitonin Monitoring in Critically Ill Adults for Early Identification and Treatment of Sepsis

The Use of Procalcitonin Monitoring in Critically Ill Adults for Early Identification and Treatment of Sepsis St. Catherine University SOPHIA Master of Arts in Nursing Theses Nursing 4-2012 The Use of Procalcitonin Monitoring in Critically Ill Adults for Early Identification and Treatment of Sepsis Raquel DeLaMater

More information

A BRIEF HISTORY OF SEPSIS. Euan Mackay

A BRIEF HISTORY OF SEPSIS. Euan Mackay A BRIEF HISTORY OF SEPSIS Euan Mackay Aims History of sepsis definition Validity of new definition Hippocrates 4 th century BC Hippocrates introduced the term "σήψις the process of decay or decomposition

More information

International Journal of Advanced Research in Biological Sciences ISSN : Research Article

International Journal of Advanced Research in Biological Sciences ISSN : Research Article International Journal of Advanced Research in Biological Sciences ISSN : 2348-8069 www.ijarbs.com Research Article Serum level of IL-6, IL-10 and PCT as a prognostic marker in post traumatic sepsis patients.

More information

Sepsis Management Update 2014

Sepsis Management Update 2014 Sepsis Management Update 2014 Laura J. Moore, MD, FACS Associate Professor, Department of Surgery The University of Texas Health Science Center, Houston Medical Director, Shock Trauma ICU Texas Trauma

More information

PRELIMINARY PROGRAMME

PRELIMINARY PROGRAMME www.sepseast2018.com PRELIMINARY PROGRAMME NOVEMBER 15-17, 2018 Danubius Health Spa Resort Helia Budapest, Hungary PROGRAM 15 NOVEMBER 2018, THURSDAY 08:20-08:30 WELCOME! Zsolt Molnar, Hungary 08:30-09:45

More information

SEPSIS & SEPTIC SHOCK

SEPSIS & SEPTIC SHOCK SEPSIS & SEPTIC SHOCK DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none Steps taken to review and mitigate potential bias

More information

Effectively Managing Sepsis Denials

Effectively Managing Sepsis Denials Effectively Managing Sepsis Denials Krysten Brooks, RN, BSN, MBA Senior Inpatient Consultant 3M Health Information Systems This is the Full Title of a Session Atlanta, GA 1 Learning Objectives At the completion

More information

Biochemical and Hematological Markers of Inflammation Accurately Predict Sepsis and its Severity in ICU Patients

Biochemical and Hematological Markers of Inflammation Accurately Predict Sepsis and its Severity in ICU Patients Sysmex Journal International Volume 29 No.1 (2019) Published 8 March, 2019 Original Article ISSN 2434-7825 Biochemical and Hematological Markers of Inflammation Accurately Predict Sepsis and its Severity

More information

Jawad Nazir, MD, FACP Medical Director, Infection Prevention and Control Avera Health and Avera McKennan Hospital Clinical Associate Professor of

Jawad Nazir, MD, FACP Medical Director, Infection Prevention and Control Avera Health and Avera McKennan Hospital Clinical Associate Professor of Jawad Nazir, MD, FACP Medical Director, Infection Prevention and Control Avera Health and Avera McKennan Hospital Clinical Associate Professor of Medicine Sanford School of Medicine, Univ of South Dakota

More information

Pathologic Mechanisms of Septic Shock

Pathologic Mechanisms of Septic Shock Pathologic Mechanisms of Septic Shock Kenneth J. Goodrum, Ph.D. Dept. Biomedical Sciences Ohio University College of Osteopathic Medicine Outline of Topics Definitions: SIRS, sepsis, shock, MODS Morbidity/mortality

More information

8/28/2015. ACP Toolbox SYSMEX CLINICAL SUPPORT TEAM SYSMEX CUSTOMER RESOURCE CENTER. Maggie Fischer BSN, RN, MS Carolyn Williams, BSN, RN, CRNI

8/28/2015. ACP Toolbox SYSMEX CLINICAL SUPPORT TEAM SYSMEX CUSTOMER RESOURCE CENTER. Maggie Fischer BSN, RN, MS Carolyn Williams, BSN, RN, CRNI ACP Toolbox Maggie Fischer BSN, RN, MS Carolyn Williams, BSN, RN, CRNI SYSMEX CLINICAL SUPPORT TEAM Available to provide education and resources: Tailored presentations Customer Resource Center tools Current

More information

SEPSIS: Seeing Through the. W. Graham Carlos MD, MSCR, ATSF, FACP

SEPSIS: Seeing Through the. W. Graham Carlos MD, MSCR, ATSF, FACP SEPSIS: Seeing Through the W. Graham Carlos MD, MSCR, ATSF, FACP Objectives Forget everything you have known about sepsis Learn new things Objectives Define sepsis Explain why Early Goal Directed Therapy

More information

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust The Septic Patient Dr Arunraj Navaratnarajah Renal SpR Imperial College NHS Healthcare Trust Objectives of this session Define SIRS / sepsis / severe sepsis / septic shock Early recognition of Sepsis The

More information

ALSO AVAILABLE: biomérieux S.A Marcy l Etoile France Tel. : 33 (0) Fax : 33 (0)

ALSO AVAILABLE: biomérieux S.A Marcy l Etoile France Tel. : 33 (0) Fax : 33 (0) 12-13 / 9304555 010/GB/A / This document is not legally binding. biomérieux reserves the right to modify specifications without notice / BIOMERIEUX, the blue logo, and Empowering Clinical Decisions and

More information

number Done by Corrected by Doctor موسى العبادي

number Done by Corrected by Doctor موسى العبادي number 12 Done by Corrected by Doctor موسى العبادي Morphology of Granulomatous Inflammations The first image (left) shows a lung alveolus in which necrosis is taking place. The image below it shows the

More information

Nothing to disclose 9/25/2017

Nothing to disclose 9/25/2017 Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Nothing to disclose 1 Explain

More information

9/25/2017. Nothing to disclose

9/25/2017. Nothing to disclose Nothing to disclose Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Explain

More information

Sepsis Early Recognition and Management. Therese Hughes, PhD, MPA, RN

Sepsis Early Recognition and Management. Therese Hughes, PhD, MPA, RN Sepsis Early Recognition and Management Therese Hughes, PhD, MPA, RN 1 Sepsis a Deadly Progression Affects millions around the world each year, killing one in four Contributes to approximately 50% of all

More information

TERMINOLOGY SIRS 10/30/2014 SURVIVING SEPSIS: FROM THE OFFICE TO THE ICU

TERMINOLOGY SIRS 10/30/2014 SURVIVING SEPSIS: FROM THE OFFICE TO THE ICU Lisa Johnson DrNP, CRNP, ACNP BC Director, AG ACNP Program, DeSales University ACNP with Eastern Pennsylvania Infectious Disease Associates SURVIVING SEPSIS: FROM THE OFFICE TO THE ICU TERMINOLOGY Infection

More information

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis

More information

Inflammatory Statements

Inflammatory Statements Inflammatory Statements Using ETCO 2 Analysis in Sepsis Syndromes George A. Ralls M.D. Orange County EMS System Sepsis Sepsis Over 750,000 cases annually Expected growth of 1.5% per year Over 215,000 deaths

More information

Sepsi: nuove definizioni, approccio diagnostico e terapia

Sepsi: nuove definizioni, approccio diagnostico e terapia GIORNATA MONDIALE DELLA SEPSI DIAGNOSI E GESTIONE CLINICA DELLA SEPSI Giovedì, 13 settembre 2018 Sepsi: nuove definizioni, approccio diagnostico e terapia Nicola Petrosillo Società Italiana Terapia Antiinfettiva

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author What room for biomarkers in the management of anti-infective therapy Philippe Montravers Hôpital Bichat-Claude Bernard, Pole SUPRA APHP UFR Paris Diderot, Paris 7, Paris Cité Sorbonne Disclosures Speaker

More information

Sepsis and Shock States

Sepsis and Shock States Sepsis and Shock States Presented By: Cynthia Webner BSN, RN, CCRN, CMC www.cardionursing.com CNEA 2009 1 INFECTION Inflammatory response to microorganisms, or Invasion of normally sterile tissues SYSTEMIC

More information

No conflicts of interest to disclose

No conflicts of interest to disclose No conflicts of interest to disclose Introduction Epidemiology Surviving sepsis guidelines 2012 Updates Resuscitation protocols Map Goals Transfusion Sepsis-3 Bundle Management Questions Sepsis is a systemic,

More information

Diagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire

Diagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire Diagnosis and Management of Sepsis and Septic Shock Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire Financial: none Disclosures Objectives: Identify physiologic principles of septic

More information

6/29/2017. Role of Biomarkers in the Management of Heart Failure Patients. What s New in Biomarkers for HF Patients?

6/29/2017. Role of Biomarkers in the Management of Heart Failure Patients. What s New in Biomarkers for HF Patients? What s New in Biomarkers for HF Patients? Role of Biomarkers in the Management of Heart Failure Patients Lori B. Daniels, MD, MAS, FACC Professor of Medicine Director, Cardiovascular Intensive Care Unit

More information

Global Updates on Sepsis. Lizzie Barrett Nurse Educator, Intensive Care Unit Nepean Hospital, Sydney, Australia Prepared August 2016

Global Updates on Sepsis. Lizzie Barrett Nurse Educator, Intensive Care Unit Nepean Hospital, Sydney, Australia Prepared August 2016 Global Updates on Sepsis Lizzie Barrett Nurse Educator, Intensive Care Unit Nepean Hospital, Sydney, Australia Prepared August 2016 The global picture Sepsis affects approx. 30 million people worldwide

More information

Sepsis: Identification and Management in an Acute Care Setting

Sepsis: Identification and Management in an Acute Care Setting Sepsis: Identification and Management in an Acute Care Setting Dr. Barbara M. Mills DNP Director Rapid Response Team/ Code Resuscitation Stony Brook University Medical Center SEPSIS LECTURE NPA 2018 OBJECTIVES

More information

INFECTION/ INFLAMMATION

INFECTION/ INFLAMMATION HAEMATOLOGY OCTOBER 2017* WHITE PAPER INFECTION/ INFLAMMATION Novel haematological parameters for rapidly monitoring the immune system response Patients with inflammatory disease are common on hospital

More information

Advancements in Sepsis

Advancements in Sepsis Objectives Advancements in Sepsis Brian Gilbert, PharmD PGY-1 Pharmacy Resident Jackson Memorial Hospital 3/13/2016 www.fshp.org Pharmacist objectives Review recent updates in resuscitation strategies

More information

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program Sepsis 3 & Early Identification David Carlbom, MD Medical Director, HMC Sepsis Program Disclosures I have no relevant financial relationships with a commercial interest and will not discuss off-label use

More information

OHSU. Update in Sepsis

OHSU. Update in Sepsis Update in Sepsis Jonathan Pak, MD June 1, 2017 Structure of Talk 1. Sepsis-3: The latest definition 2. Clinical Management - Is EGDT dead? - Surviving Sepsis Campaign Guidelines 3. A novel therapy: Vitamin

More information

Sepsis: Update on Diagnosis, Evaluation and Management

Sepsis: Update on Diagnosis, Evaluation and Management Sepsis: Epidemiology Sepsis: Update on Diagnosis, Evaluation and Management Michael J. Apostolakos, MD Professor of Medicine Director of Adult Critical Care University of Rochester ~ 750,000 cases per

More information

Clinical Guide to Use of PROCALCITONIN. for Diagnosis and Guidance of Antibiotic Therapy

Clinical Guide to Use of PROCALCITONIN. for Diagnosis and Guidance of Antibiotic Therapy Clinical Guide to Use of PROCALCITONIN for Diagnosis and Guidance of Antibiotic Therapy THE CONTENT OF THIS BOOKLET WAS KINDLY WRITTEN BY: Philipp SCHUETZ, MD, MPH Privat Dozent for Endocrinology and Internal

More information

Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHE II scores in patients with sepsis

Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHE II scores in patients with sepsis Research Report Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHE II scores in patients with sepsis Journal of International Medical Research

More information

Update on Sepsis Diagnosis and Management

Update on Sepsis Diagnosis and Management CHAPTER 12 Update on Sepsis Diagnosis and Management Kevin Alexander, DPM INTRODUCTION Sepsis and septic shock have become a large problem in the health care system that affects at least 1 million people

More information

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 本檔僅供內部教學使用檔案內所使用之照片之版權仍屬於原期刊公開使用時, 須獲得原期刊之同意授權 Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 Definition Sepsis the presence of infection with

More information

Use of Blood Lactate Measurements in the Critical Care Setting

Use of Blood Lactate Measurements in the Critical Care Setting Use of Blood Lactate Measurements in the Critical Care Setting John G Toffaletti, PhD Director of Blood Gas and Clinical Pediatric Labs Professor of Pathology Duke University Medical Center Chief, VAMC

More information

Sepsis Update: Early Identification and Management

Sepsis Update: Early Identification and Management Sepsis Update: Early Identification and Management Q&A From the Live Webinar Presenter: Tom Ahrens, RN, PhD, FAAN Live webinar: Thursday, May 09, 2013 The AACN Critical Care Webinar Series is not only

More information

Sepsis Awareness and Education

Sepsis Awareness and Education Sepsis Awareness and Education Meets the updated New York State Department of Health (NYSDOH) requirements for Infection Control and Barrier Precautions coursework Element VII: Sepsis Awareness and Education

More information